Common TitleALLY-2
Official Title Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1
Phase Phase III
ClinicalTrials.gov NCT02032888
Treatments
Daclatasvir
Daclatasvir
Tradename:DaklinzaOther Names:DCVClass:DiscontinuedFunding
IndustryBristol-Myers Squibb